BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study (Q48482815)

11 February 2018

title

BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study (English)

1 reference

11 February 2018

author name string

Rieger L

1

1 reference

11 February 2018

Weller M

2

1 reference

11 February 2018

Bornemann A

3

1 reference

11 February 2018

Schabet M

4

1 reference

11 February 2018

Dichgans J

5

1 reference

11 February 2018

Meyermann R

6

1 reference

11 February 2018

publication date

1 February 1998

1 reference

11 February 2018

Journal of the Neurological Sciences

published in

1 reference

11 February 2018

volume

155

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

68-75

1 reference

11 February 2018

The p53 gene and its role in human brain tumors.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Biochemical properties and biological effects of p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Inactivation of Bcl-2 by phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

p53 in tumour pathology: can we trust immunohistochemistry?--Revisited!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

The retinoblastoma gene is involved in malignant progression of astrocytomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Apoptosis. Its significance in cancer and cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Functions of pRb and p53: what's the connection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

The tumor suppressor genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Comparative study of p53 gene and protein alterations in human astrocytic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

bcl-2 protein expression in tumors of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900277-3

10.1016/S0022-510X(97)00277-3

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018